Biomaterial-associated infection is a serious complication of modern implantation surgery.
INTRODUCTION
Biomaterial-associated infection is a serious complication of modern implantation surgery which often leads to prolonged patient pain and functional losses. The removal of an infected implant is the final outcome of most of these infections, generating high costs for the health-care system and discomfort for the patient. Biomaterial infections are developed on the implant surface due to the ability of microorganisms to get attached and to further form biofilms [1] . Therefore, the study and the improvement of the implant surface to avoid the first stage for the biofilm formation of the pathogenic microorganism is required. To overcome implant-related infection and bacterial load on the implant surface, antibiotic drug incorporation and its controlled release can be a promising strategy. Implantable drug-eluting devices (or implantable drug delivery systems-DDS) offer several advantages over conventional drug delivery methods. For instance, they can provide localized, site-specific drug delivery, which is especially important in applications such as cardiology and oncology, where targeted delivery can improve the effectiveness of treatment and minimize side effects or damage to healthy tissue [2] . The design of DDS highly relies on polymers, which is driven by the suitability of physicochemical, mechanical and processability of the polymer-based formulations [3] .
Synthetic polyesters, poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and their copolymers, polycaprolactone (PCL), poly(lactic-co-glycolic acid) (PLGA) are examples of biodegradable polymers used for DDS [4, 5] . Lately, natural polyesters polyhydroxyalkanoates (PHAs) emerged as a vast family of potential candidates as biodegradable polymers for DDS. Polyhydroxybutyrate (PHB) a n d i t s c o pol y m e r Poly(3-hydroxyvalerate) (PHBV) which is less crystalline, and more flexible than PHB itself [6] , are members of this family of biopolymers. PHAs are primarily characterized by the fact that they are produced by microorganisms from removable resources, and, therefore, they exhibit superior traits with respect to synthetic polymers such as the prevention of toxic products from chemical polymerization [7] . Furthermore, the by-products of their hydrolytic degradation make it possible to obtain common blood constituents (a ketone body produced by the liver from fatty acids, ketogenesis) [8] . Pas have performed well in a number drug delivery applications due to their excellent biocompatibility, non-toxicity and biodegradability [3, 9, 10, 11, 12, 13] . Metal-based drug eluting systems have received little attention in the literature in comparison to polymer-based systems. So far, only intramedullary nails with a PDLLA coating containing gentamicin were placed on the market [14] . For example, metal implants such as plates and wires have been coated with a polymer matrix layer loaded with a microbial antibiotic, while others have studied different therapeutic agents including triclosan and chlorhexidine (CHX) [15, 16, 17] . In such studies, however, in vitro antibiotic release experiments showed that most of the drug was released within several hours after exposure to an aqueous environment. Even in the most favorable case, the system was only able to provide the desired drug release for less than 12 days [18, 19] . Therefore, long-term release drug delivery systems are required. In this research, we develop and study novel gentamicin-loaded PHAs coatings on titanium implants designed to serve as devices to prevent implantassociated infections by a gentamicin-controlled release phase. We pay special attention to maintaining suitable concentrations of antibiotics for long periods of time, since it is essential for treating highly resistant infections.
MATERIAL AND METHODS

. Materials
Titanium bar was obtained from c.p. grade 2 Ti provided by Technaloy S.A. The bar was cut into disks that were 3 mm thick and 10 mm in diameter. PHB and PHBV were kindly provided by Dr. Martin Koller (Institute of Biotechnology and Biochemical EngineeringGraz University of Technology). These PHAs were biosynthesized by Cupriavidus necator and glucose was the main carbon source used in their fermentations. The used antibiotic was gentamicin sulfate (Genta; C 21 H 43 N 5 O 7 , MW 477.596 g/mol, freely soluble in water), which was purchased by Sigma-Aldrich. Chemical products such as hydrogen peroxide, Trichloromethane (TCM), poly(vinyl alcohol) (PVA) were purchased from Sigma Chemical Co. and used without further purification.
Biopolymer Characterization
The molecular masses of the biopolymers were analyzed via gel performance chromatography (GPC). Chloroform was utilized as an eluent at a flow rate of 0.80 ml min -1 with a stabilization pressure of 35 bars and a sample concentration of 1.5 mg ml -1 .
A Waters Styragel HT column for midrange molecular-mass distributions was used, and samples of polystyrene with different molecular masses were used as standard. The chemical structure of both polymers and monomer composition of PHBV were determined by Proton Nuclear Magnetic Resonance ( 1 H NMR) [20] . Spectra were recorded at 25°C on a Bruker AM300 spectrometer. The polymer samples were dissolved in chloroform and a drop of TMS (tetra methyl silane used as internal standard for calibrating chemical shift for 1 H) was added as reference. 10 mg of the sample dissolved in 1 ml of deutered solvent was used. Proton spectra were recorded at 300.1 MHz with a spectrum of 32 K data points. A total of 64 scans were utilized with a relaxation delay of 1 s.
Surface treatment procedures
Mirror-like, smooth surfaces were achieved by grinding with SiC papers of decreasing grit size (from P800 to P2400-European P-grade standard), followed by polishing with suspensions of alumina particles on cotton cloths containing hydrogen peroxide (6 µm and 1 µm particle size). Prior to chemical activation, samples were ultrasonically rinsed with cyclohexane, isopropanol, distilled water, ethanol and acetone. Samples were stored dry under a vacuum. Oxygen plasma technique (Plasma): Surface cleaning and activation were carried out by means of plasma cleaning (Plasma Cleaner, Sterilizer PDC-002, Harrick Scientific Corporation, USA). After oxygen purging and high vacuum (3 times) the samples were exposed at low electromagnetic radiofrequency radiation (between 8 and 12 MHz) for 10 min. Sodium hydroxide treatment (NaOH): The Ti disks were immersed in 5 M of previously prepared NaOH in closed polypropylene flasks. They were placed into a furnace at 60 ºC for 24 h. Afterwards the samples were cleaned and immersed in Milli-Q water for 30 min, then rinsed with water of the same quality and acetone. They were dried with nitrogen and, finally, stocked in a vacuum. al [12, 13] . Simple emulsion was carried out by PHB solving in chloroform (10 mL) (organic phase). Then, 2 mL of aqueous solution of Genta with 2% PVA was emulsified into the previous organic solution under ultrasonic homogenizer at 5W (3 min at 60%) (Bandelin Sonopuls with microtip MS 73). Different concentrations of Genta (10% and 30% (w/w) of the polymer mass) and polymer (5, 10, 20 and 40 mg/mL) were studied.
Drug/ biopolymer matrix preparation
Gentamicin
Dip-Coating process
The previously descri bed solut ions (gent am icin di spersi on and daily fresh prepared W/ O emulsion) were used to coat Ti surfaces by dip-coating technique.
KSV NIMA Dip Coater (Nima instruments, Stockholm, Sweden) was used with a single vessel and KSV NIMA Dip Coaters software. The substrate was immersed with a constant rate of 10 mm/min and it was extracted with a controlled output rate of 70 mm/min. The process was performed at room temperature (22 ºC). Different numbers of immersions were studied (1, 3 and 6 times dip-coating), being assured that each coating was totally dried between every immersion. Different combinations of immersions were also tested, with a range of concentrations of gentamicin sulfate in each immersion. 
Drug delivery characterization
Release of gentamicin sulphate from the coated Ti surfaces was evaluated. In vitro release profiles were obtained by immersing coated samples in 10 mL phosphate buffer solution (PBS) (pH 7.40) under conditions of mild stirring. The vials were incubated at 37 ºC. At predetermined intervals, 1 mL of release media was taken to assay drug concentration, while a fresh PBS replaced the same volume [22] . In order to determine the amount of released drug, mass spectroscopy was used (Varian 500-MS) using a Zorbax Eclipse XVB-C18 column (4,6x150 mm, 5µm, 80Å). This evaluation was performed three times per sample.
Biological characterization
Human osteoblast-like Saos-2 cells were cultured in McCoy's 5A medium (SigmaAldrich) supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin (50 U/mL and 50 µg/mL, respectively), 2 mM L-glutamine, 1 mM sodium pyruvate and 20 mM HEPES buffer at 37 ºC in a humidified atmosphere at 5% CO 2 , all from Invitrogen.
Cells were harvested at confluence using TrypLE (Invitrogen) and seeded at a cell density of 1 × 10 4 cells/well. Cell citotoxicity assay: Indirect in vitro cytotoxicity tests of the treated surfaces of Saos-2 cells were carried out by analyzing the activity of the lactate dehydrogenase (LDH) enzyme by the Cytotoxicity Detection Kit LDH. Each specimen was immersed in DMEM for 72 h at 37 ± 2 °C with an extraction medium area/volume ratio of 0.5 cm 2 /1 mL (according to ISO 10993-5). Afterward, the extraction medium was removed and diluted with DMEM (dilution 1/0; 1/1; 1/10; 1/100; 1/1000). As a reference for 100% maximum survival, cells were placed in TCPS (Tissue culture polystyrene). In vitro antibacterial assay: A commonly used procedure for studying the antibacterial action was followed [23, 24] . The assay was performed with 
Statistical studies
Surface characterization and biological results were expressed as a mean value of standard deviation (SD) for each sample. T-test was used with a 95% confidence interval to evaluate statistical differences.
RESULTS AND DISCUSSION
In order to obtain surfaces with antibacterial activity, coatings of PHAs loaded with Genta as an antibiotic were used to cover Ti surfaces. There has been an increasing interest in the use of natural materials as drug delivery vehicles due to their appealing properties. The natural origin, biodegradability, and biocompatibility of PHAs make them suitable for a variety of applications in the health industry [10, 25, 26] . Particularly because of their property of biodegradation, PHAs were studied as a matrix for the antibiotic and as a controlled drug delivery system.
Biopolymer characterization
The biopolymer molecular masses were analyzed by GPC and the results show similar MW for both biopolyesters: 240 kDa for PHB and 270 kDa for PHBV with polydispersity index (PDIs) of 8.6 and 3.4, respectively ( figure 2 C and D) . H 1 NMR was carried out to verify the biopolymers structure ( figure 2 A and B) . The characteristic peaks at 0.99 ppm and 1.25 ppm for methyl group for valerate and hydroxybutyrate monomers, respectively, can be used to determine the valeric composition in the copolymer PHBV sample according to equation 1 [27, 28] :
It was confirmed that PHBV has 19 mol% of the monomer HV. The presence of this monomer decreases the polymer crystallinity and, thus, its mechanical properties change (high elastic modulus and flexural strength with low tensile strength and elongation at break) [29] and degradability [30] . Such different properties directly influence the features of the coatings with both polymers. 
Ti activation technique characterization
Oxygen plasma and NaOH treatments were used to modify Ti surfaces. Both methods allow modification of surfaces by attachment or adsorption of functional groups to tailor surface properties for specific applications. In particular, both methods chemically remove organic contaminants and promote surface oxidation and hydroxylation (OH groups) by increasing surface wettability [31] . Especially, chemical treatment in alkali solutions is a strong contender to impart submicron or nano-roughness to Ti surfaces [32, 33, 34] . NaOH treatment generates a homogeneous roughness on Ti surface with a very intricate and nano-porous morphology, whereas plasma cleaning did not modify the surface roughness (compare figure 3 B and C) . The corresponding profile roughness parameter Ra has been included on the micrographs. Biopolymers solutions (PHB and PHVB) were prepared to study their wettability and affinity to the activated Ti surfaces.
The contact angles of both biopolymer solutions are significantly lower on the Ti surface treated with NaOH ( figure 3D ). This improvement of surface affinity to the biopolymer solutions is explained due to the incorporation of higher OH groups on the Ti surfaces, which allow the bounding with the carboxylic groups at the end of the biopolymers chain via Van der Waals bounds. This affinity is greater with PHB, probably due to its lower MW and higher PDI than PHBV. This lower MW and higher PDI leads to a greater number of shorter polymer chains. Therefore, PHB shows a greater number of ending groups, carboxylic group, which easily bond with OH groups, than PHBV.
According to the literature, NaOH etching is the most efficient activation method for promoting surface hydroxylation (incorporation of OH groups) increasing its surface wettability and its specific area. Higher roughness and consequently more specific surface for samples chemically treated, probably, benefit the physical absorption of the biopolymer solutions. Therefore, chemical activation with NaOH solution was the activation method selected for further studies. 
Emulsion preparation
Since gentamicin is not soluble in the same solvents as PHB and PHBV, a dispersion of the particles in the biopolymers solution was prepared and used in a first attend to further cover the Ti surface by dip-coating. Unfortunately, a homogeneous distribution of gentamicin particles dispersed in the polymer coating was not achieved; Genta particles were in most cases too big and they tended to cluster. Figure 4 shows Ti surface after dip-coating with Genta dispersed in PHB/chloroform solution. In order to obtain an optimal homogeneity of the antibiotic in the biopolymer matrix, emulsions of the drug in the biopolymer solution were proposed as fluids for the process of surface covering via dipcoating. Following previous reported studies for PHA emulsion preparation [13] , an aqueous solution of Genta with 2% PVA was emulsified into the organic solution (biopolymer in chloroform) using an ultrasonic homogenizer. The strategy of using water in oil (W/O) emulsions as a fluid for dip-coating technique was appropriate to obtain uniform distributions of gentamicin sulfate in the coating. 5G ). This porous structure will promote drug release, since it shows higher specific surface, exposing the biopolymer to a higher degradation. These porosities or cavities could also provide for space for the cells to grow among the coating, thus improving their biointegration. The amount of Genta in the emulsion did not modify this results. The water contact angle was measured on the PHB and PHBV coating surfaces. They normally show high contact angles of 60-90 degrees [36] . However, a drop of water was immediately absorbed by the substrate, possibly due to the topography of the surfaces. 
Toxicity assay and cell adhesion
The conditions studied were the ones exhibiting great risk of toxicity; coatings with six times the process of dip-coatings and 30% gentamicin sulfate, since the antibiotic content is the highest. 
Drug delivery studies
The technique of delivery must guarantee a rapid release of the antibiotic from the carrier, and local drug levels above the minimal inhibitory concentration (MIC). For gentamicin, these limits are: MIC50=0.5 µg/mL and MIC90=32.0 µg/mL [37] . Genta release profiles from PHB and PHBV coatings of 3 and 6 immersions are shown in figure 7A . In terms of initial drug release and release rate, there are no remarkable differences between coatings made with 3 or 6 immersions. As expected, lower amount of drug is released when the number of dip-coating is less, since there is fewer antibiotic incorporated to the bulk of the polymer matrix. The release profiles show a fast liberation of gentamicin the first 24 hours of incubation, afterward drug release rate decreases, and it is maintained until the end of the incubation. According to these experimental results, release of the active principle from the biopolymer matrix takes place in two stages. In the early hours of incubation, gentamicin is released from the surface of the coating.
Once the external gentamicin is totally released, then the polymer matrix must be degraded to liberate the remaining active principle inside the bulk. Comparing both PHAs, the initial drug released from PHB coatings is higher than from PHBV ones, regardless of the number of immersions. While having the same number of dip-coatings and the same drug concentration, PHB samples incorporate more active principle than PHBV. This can be corroborated by the coating weight, which is higher for the PHB coatings (figure 5H), and it can be related to the chemical or physical interaction between the drug and the biopolymer.
PHB has lower MW and higher PDI than PHBV, consequently it shows a higher number of carboxyl groups placed at the end of the biopolymer chains. This chemical group can easily bond with the hydroxyl and amine groups from gentamicin, giving to PHB coatings more affinity to the active principle.
In the second stage of drug release, PHB samples do not reach the minimum inhibitory concentrations (MIC50 = 0.0005 mg/mL) required for antimicrobial properties in some cases, while samples with PHBV show drug release above MIC limit in all cases. This can be explained by two reasons. First, the better affinity (and linkage) that PHB exhibits for gentamicin sulfate compared to PHBV, prevents it from being readily released.
PHBV can more easily loosen its chemical bonds with gentamicin, thus, releasing it easily. The second reason is related with the different degradation rates of both biopolymers, since the polymer matrix has to be degraded in order to release the drug located inside the coating. PHBV has shown faster degradation than PHB due to its lower crystallinity [38] . It is reported that when stored at 37°C for 6 months in human blood serum PHB degrades very slowly with a weight loss of 5% [39] . Moreover, the high porosity that PHBV shows affects its degradation process, and, consequently, the drug delivery. This has been confirmed by studying the stability of biopolymer coatings.
After two weeks of incubation under physiological conditions (PBS and 37°C) the initial morphology of biopolymer coating surfaces changed, revealing early signs of degradation ( Figure 7B ). Holes can be observed on the surfaces of PHB coating after their exposure to PBS for two weeks, while smooth surfaces can be detected on initial coatings ( figure 5C ). The more rapid rate of degradation of PHBV with respect to PHB can be inferred from both the range of holes sizes and the roughness of the surface of the highly porous network of PHBV coatings ( Figure 7B , PHBV inset). Given the drug profile of PHBV, and, in consideration of the results described above it can be confirmed that confirmed that PHBV coatings allow the release of enough quantity of drug (above MIC value) to maintain antimicrobial properties for longer periods of time. 
In vitro antibacterial assay
Determination of bacterial growth inhibition was performed with both Gram-positive and
Gram-negative bacteria (Staphylococcus aureus and Escherichia coli, respectively). All cases tested (PHBV coatings with 1, 3 and 6 immersions and with 10 and 30% Genta) show growth inhibition of both microorganisms, indicating that Genta released is above 0.0005 mg/mL, according to the literature [37] . There was a slight increase in the diameter of the inhibitory growth zone when the concentration of Genta was higher and also when the number of dipcoatings increased. The diameter of the halo is then proportional to the percentage of drug concentration, and the number of immersions. The effect of the antibiotic on both bacteria is very similar (without significant differences), although gentamicin is reported to have a stronger effect on Gram-negatives such an E. coli [40] . Ti discs with PHBV coating with different dip-coatings (3 and 6) and with both, simple (30%) (figure 9A) and combined 
Conclusions
A drug delivery system for an application involving gentamicin was developed in this study by using a dip-coating technique to achieve an optimum coating on Titanium surfaces using biodegradable biopolymers, PHB and PHBV. The dip-coating technique makes it possible to combine layers with varying drug concentrations in order to obtain distinct coatings with a range of drug release profiles. In this study, the optimal conditions for applying dip-coating technique for obtaining an optimal drug delivery were achieved. The optimal release profiles obtained exceeded, for all intervals of time tested, the minimum concentration for the 
